We serve Chemical Name:2-benzyl-5-methyl-4H-pyrazol-3-one CAS:946-23-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-benzyl-5-methyl-4H-pyrazol-3-one
CAS.NO:946-23-6
Synonyms:1-benzyl-3-methyl-5-pyrazolone;2-benzyl-5-methyl-2,4-dihydropyrazol-3-one;1-Benzyl-3-methylpyrazolone-5;2-Benzyl-5-methyl-2H-pyrazol-3-ol;2-benzyl-5-methyl-1,2-dihydro-pyrazol-3-one;EINECS 213-416-4;2-Benzyl-2,4-dihydro-5-methyl-3H-pyrazol-3-one;2,4-dihydro-2-benzyl-5-methyl-3H-pyrazol-3-one;2-benzyl-1,2-dihydro-5-methyl-3H-pyrazol-3-one;2-benzyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one;1-Benzyl-3-methylpyrazolin-5-one;2-Pyrazolin-5-one,1-benzyl-3-methyl;1-benzyl-3-methyl-2-pyrazolin-5-one
Molecular Formula:C11H12N2O
Molecular Weight:188.22600
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:304.7ºC at 760 mmHg
Density:1.14g/cm3
Index of Refraction:1.593
PSA:32.67000
Exact Mass:188.09500
LogP:1.16830
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-benzyl-3-methyl-5-pyrazolone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-3-methyl-2-pyrazolin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-benzyl-5-methyl-2,4-dihydro-3H-pyrazol-3-one Use and application,2,4-dihydro-2-benzyl-5-methyl-3H-pyrazol-3-one technical grade,usp/ep/jp grade.
Related News: Prime Minister Naftali Bennett, launching the campaign, said President Isaac Herzog would be the first to receive the booster, on Friday. 5-(furan-2-yl)-3-methoxy-1,2,4-triazine manufacturers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. N-(1-propenyl)-N-p-toluenesulfonyl-2-vinylaniline suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 2-Pyrrolidinone, 1-[[3,5-bis(trifluoromethyl)phenyl]sulfonyl]-4-hydroxy- vendor & factory.
